Not for Human Consumption: How Grey‑Market Peptides Built a Parallel Pharma System
TL;DR An investigation of grey‑market peptides shows a growing parallel pharmaceutical ecosystem: from advanced, clinically validated GLP‑1/GIP/glucagon agonists to widely…